Wei Cui

2.5k citations

86 papers · 1.8k indexed · h-index 22

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in ⓘ

Hematology 24
- Acute Myeloid Leukemia Research 13
- Multiple Myeloma Research and Treatments 12
Genetics 18
- Chronic Lymphocytic Leukemia Research 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5

Co-authors: Diane L. Persons (4 shared papers)Jill C. Pelling (2 shared papers)Eugenia M. Yazlovitskaya (2 shared papers)James P. Luyendyk (3 shared papers)Bryan L. Copple (3 shared papers)Chunfu Wu (3 shared papers)Jessica A. Williams (1 shared paper)Hong-Min Ni (1 shared paper)
Journals: Blood (4 papers)American Journal of Clinical Pathology (3 papers)Cell Reports (2 papers)Modern Pathology (2 papers)Oncotarget (2 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Wei Cui

80 papers receiving 1.8k citations

Peers

Countries citing papers authored by Wei Cui

Since Specialization

Citations

This map shows the geographic impact of Wei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cui more than expected).

Fields of papers citing papers by Wei Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cui. The network helps show where Wei Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Cui Line = papers co-authored together Wei Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. PubMed ·Diane L. Persons, Eugenia M. Yazlovitskaya, Wei Cui, Jill C. Pelling	1999	223
2	Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy Journal of Hepatology ·Hong-Min Ni, Benjamin L. Woolbright, Jessica A. Williams, Bryan L. Copple, Wei Cui, James P. Luyendyk, Hartmut Jaeschke, Wen-Xing Ding	2014	219
3	The combination of disulfiram and copper for cancer treatment Drug Discovery Today ·Hong Li, Jingyu Wang, Chunfu Wu, Lihui Wang, Zhe‐Sheng Chen, Wei Cui	2020	139
4	ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma Modern Pathology ·Lang Yang, Yong Ren, Xi Yu, Feng Qian, Baishijiao Bian, Hualiang Xiao, Weiguang Wang, Senlin Xu, H. J. Yang, Wei Cui, Qiang Liu, Zhe Wang, Wei Guo, Gang Xiong, Kang Yang, Cheng Qian, Xia Zhang, Peng Zhang, You‐Hong Cui, Xiu‐Wu Bian	2013	107
5	Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells Oncotarget ·Xinwei Liu, Lihui Wang, Wei Cui, Xiangzhong Yuan, Lulu Lin, Qi Cao, Nannan Wang, Yi Li, Wei Guo, Xun Zhang, Chunfu Wu, Jingyu Yang	2016	87
6	β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma Cancer Research ·Chuan Xu, Dan Xie, Shi‐Cang Yu, Xiao‐Jun Yang, Li-Ru He, H. J. Yang, Yi-Fang Ping, Bin Wang, Lang Yang, Sen-Lin Xu, Wei Cui, Qing-Liang Wang, Wen-Juan Fu, Qing Liu, Cheng Qian, You-Hong Cui, Jeremy N. Rich, Hsiang‐Fu Kung, Xia Zhang, Xiu‐Wu Bian	2013	79
7	Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines Molecular Carcinogenesis ·Wei Cui, Eugenia M. Yazlovitskaya, Matthew S. Mayo, Jill C. Pelling, Diane L. Persons	2000	69
8	Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis Toxicology and Applied Pharmacology ·Hong Lü, Wei Cui, Curtis D. Klaassen	2011	63
9	Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma Molecular Cancer ·Qiang Liu, Xiang Cui, Xi Yu, Baishijiao Bian, Feng Qian, Xu‐Gang Hu, Chengdong Ji, Lang Yang, Yong Ren, Wei Cui, Xia Zhang, Peng Zhang, Ji Ming Wang, You‐Hong Cui, Xiu‐Wu Bian	2017	48
10	Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy‐Defective Mouse Liver Hepatology ·Hong‐Min Ni, Xiaojuan Chao, Hua Yang, Fengyan Deng, Shaogui Wang, Qingyun Bai, Hui Qian, Yue Cui, Wei Cui, Ying‐Hong Shi, Wei‐Xing Zong, Zhengtao Wang, Li Yang, Wen‐Xing Ding	2019	47
11	Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer Oncotarget ·Zhengjun Guo, Lang Yang, Feng Qian, Yanxia Wang, Xi Yu, Chengdong Ji, Wei Cui, Dongfang Xiang, Xia Zhang, Peng Zhang, Ji Ming Wang, You‐Hong Cui, Xiu‐Wu Bian	2016	45
12	The genetic landscape of germlineDDX41variants predisposing to myeloid neoplasms Blood ·Peng Li, Sara Brown, Margaret S. Williams, Thomas A. White, Wei Xie, Wei Cui, Deniz Peker, Li Lei, Christian A. Kunder, Huan‐You Wang, Sarah Murray, Jennie Vagher, Tibor Kovacsovics, Jay Patel	2022	43
13	Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy Journal of Hepatology ·Xiaojuan Chao, Shaogui Wang, Sam Fulte, Xiaowen Ma, Forkan Ahamed, Wei Cui, Zhipeng Liu, Thomas Rülicke, Kurt Zatloukal, Wei‐Xing Zong, Wanqing Liu, Hong‐Min Ni, Wen‐Xing Ding	2021	42
14	Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. PubMed ·Senlin Xu, Sha Liu, Wei Cui, Yu Shi, Qin Liu, Jiang‐Jie Duan, Shi‐Cang Yu, Xia Zhang, You‐Hong Cui, Hsiang‐Fu Kung, Xiu‐Wu Bian	2015	41
15	Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway Oncogene ·Chengdong Ji, Lang Yang, Weijing Yi, Dongfang Xiang, Yanxia Wang, Zhi-Hua Zhou, Feng Qian, Yong Ren, Wei Cui, Xia Zhang, Peng Zhang, Ji Ming Wang, You‐Hong Cui, Xiu‐Wu Bian	2018	39
16	AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome Leukemia ·Peng Li, Thomas A. White, Wei Xie, Wei Cui, Deniz Peker, Gang Zeng, Huan‐You Wang, Jennie Vagher, Sara Brown, Margaret S. Williams, Tibor Kovacsovics, Jay Patel	2021	36
17	Therapeutic Administration of the Direct Thrombin Inhibitor Argatroban Reduces Hepatic Inflammation in Mice with Established Fatty Liver Disease American Journal Of Pathology ·Karen M. Kassel, Bradley P. Sullivan, Wei Cui, Bryan L. Copple, James P. Luyendyk	2012	36
18	Sorghum Insect Problems and Management^F Journal of Integrative Plant Biology ·Chunshan Guo, Wei Cui, Xue Feng, Yun Zhao, Guihua Lu	2010	30
19	PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies Trends in Molecular Medicine ·Christopher Nishimura, Marc C. Pulanco, Wei Cui, Liming Lu, Xingxing Zang	2020	28
20	POU5F1 Enhances the Invasiveness of Cancer Stem-Like Cells in Lung Adenocarcinoma by Upregulation of MMP-2 Expression PLoS ONE ·Yan-hong Xin, Baishijiao Bian, Xiaojun Yang, Wei Cui, Hongjuan Cui, You‐Hong Cui, Xia Zhang, Chuan Xu, Xiu‐Wu Bian	2013	28

About Wei Cui

Wei Cui is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 86 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cancer Cells and Metastasis (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Autophagy in Disease and Therapy (7 papers), Protein Degradation and Inhibitors (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (356 citations), Hematology (224 citations), Oncology (519 citations), Molecular Biology (939 citations) and Pathology and Forensic Medicine (213 citations). Wei Cui has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Diane L. Persons, Jill C. Pelling, Eugenia M. Yazlovitskaya, James P. Luyendyk, Bryan L. Copple, Chunfu Wu, Jessica A. Williams, Hong-Min Ni, Hartmut Jaeschke and Wen-Xing Ding. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Cell Reports, Modern Pathology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact